EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy of nebulized salbutamol in transient tachypnea of the newborn: A systematic review and meta-analysis

Nanthida Phattraprayoon, Nut Koonrungsesomboon, Mingkwan Na Takuathung iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0359663 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS One, 2026. Verfasst von Nanthida Phattraprayoon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand. Hauptthemen laut MEDLINE: Albuterol, Transient Tachypnea of the Newborn, Bronchodilator Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chulabhorn Royal Academy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transient tachypnea of the newborn (TTN) commonly affects near- and full-term infants and often requires respiratory support. The use of nebulized salbutamol to improve respiratory outcomes has been of interest, though its clinical efficacy remains controversial. This systematic review and meta-analysis aimed to evaluate whether nebulized salbutamol improves clinical outcomes in affected infants. We searched PubMed, Scopus, Embase, and the Cochrane Library for randomized controlled trials (RCTs) evaluating the efficacy of nebulized salbutamol in infants with TTN. We used a random-effects model to calculate mean differences (MDs) with 95% confidence intervals (CIs). Twenty-five studies were included in the systematic review, comprising seventeen RCTs for meta-analysis involving 1,317 infants. The analysis showed that salbutamol significantly decreased the duration of respiratory support (MD: −14.85 hours; 95% CI [−25.05, −4.65]; p = 0.004), duration of continuous positive airway pressure (MD: −18.19 hours; 95% CI [−30.03, −6.35]; p = 0.003), duration of oxygen requirement (MD: −24.57 hours; 95% CI [−35.03, −14.10]; p < 0.001), and length of hospitalization (MD: −1.17 days; 95% CI [−1.69, −0.65]; p < 0.001). However, there was no significant decrease in duration of tachypnea (MD: −9.93 hours; 95% CI [−25.42, 5.56]; p = 0.21) or duration of neonatal intensive care unit stay (MD: −0.84 days; 95% CI [−2.62, 0.94]; p = 0.36). Subgroup analysis for respiratory support duration showed no significant effect in infants with clinical score of TTN < 5 (MD: −10.88 hours; 95% CI [−24.48, 2.73]; p = 0.12), while the certainty of evidence for all outcomes was low to very low. Nebulized salbutamol may improve clinical outcomes relevant to the evolution of the disease in TTN infants, with potential benefits in certain subgroups such as those with greater disease severity, though the available evidence is of low to very low certainty. Therefore, our confidence in its efficacy in treating TTN remains limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuterolTransient Tachypnea of the NewbornBronchodilator AgentsHumansInfant, NewbornNebulizers and VaporizersTreatment OutcomeAdministration, InhalationContinuous Positive Airway Pressure

Substanzen

AlbuterolBronchodilator Agents

Autor:innen und Institutionen

  • Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Mingkwan Na Takuathung

Förderung

  • Chulabhorn Royal Academy

Zitieren

APA

Phattraprayoon, N., Koonrungsesomboon, N., & Na Takuathung, M. (2026). Efficacy of nebulized salbutamol in transient tachypnea of the newborn: A systematic review and meta-analysis. PLOS One. https://doi.org/10.1371/journal.pone.0359663

Vancouver

Phattraprayoon N, Koonrungsesomboon N, Na Takuathung M. Efficacy of nebulized salbutamol in transient tachypnea of the newborn: A systematic review and meta-analysis. PLOS One. 2026. doi:10.1371/journal.pone.0359663

BibTeX
@article{Phattraprayoon2026,
  author = {Phattraprayoon, Nanthida and Koonrungsesomboon, Nut and Na Takuathung, Mingkwan},
  title = {Efficacy of nebulized salbutamol in transient tachypnea of the newborn: A systematic review and meta-analysis},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0359663}
}
Kostenlos starten →